Covid and What We Peasants Can Do to Protect Ourselves

Covid and What We Peasants Can Do to Protect Ourselves

Morelaurieallee
#antiviral
Stealthy Jess 🇨🇦 💜 (@AdvancedTweaker) on X
Stealthy Jess 🇨🇦 💜 (@AdvancedTweaker) on X

“As many of you know, I've been repurposing HIV antiretroviral meds to treat my LC.

My energy and baseline have been slowly, consistently improving.

For everyone still asking me about my protocol, I put it all in one spot, where I can update as I go along.

My current meds: docs.google.com/spreadsheets/d… My current supplements: docs.google.com/spreadsheets/d…

Past threads with more info and background: x.com/AdvancedTweake…

x.com/AdvancedTweake…

Enjoy and AMA :)”

#What we can do to protect ourselves#Long Covid#Treatment#Useful#anecdote#protocols#antiviral#truvada#resources#compilations#repurposed drugs#HIV#HIV drugs for Long Covid
·x.com·
Stealthy Jess 🇨🇦 💜 (@AdvancedTweaker) on X
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 - PubMed
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 - PubMed
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
#Azelastine nasal spray#antihistamines#antiviral#treatment#spike protein#nasal treatments#protocols#What we can do to protect ourselves#prevention tips#Astelin nasal spray#Astepro nasal spray
·pubmed.ncbi.nlm.nih.gov·
Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2 - PubMed
Frontiers | Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study
Frontiers | Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study

A study in Guangzhou, China, with 248 COVID-19 patients found that Paxlovid is effective and safe when given within 10 days of onset, reducing viral load

Effectiveness decreases after 10 days, but multiple cycles may help if the viral load remains high

#Paxlovid#antiviral#treatment#early treatment
·frontiersin.org·
Frontiers | Real-world effectiveness and safety of nirmatrelvir-ritonavir (Paxlovid)-treated for COVID-19 patients with onset of more than 5 days: a retrospective cohort study
Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
Frontiers | Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
#Pomegranate#antiviral#Useful
·frontiersin.org·
Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation
Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation

"Regular consumption of berry fruits, which are rich in anthocyanin compounds, should be supportive to inhibit viral infectious by reducing of propagation and pathogenicity of SARS-CoV–2."

Need to evaluate functional foods as #LongCovid anti-virals. Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation

#anthocyanins#antiviral#Useful#protocols#berries#Discussion
·sciencedirect.com·
Berries anthocyanins as potential SARS-CoV–2 inhibitors targeting the viral attachment and replication; molecular docking simulation